ALMKT:EPA
Mauna Kea Technologies SA
0,16 €
arrow_upward
+3,58%(+0,0056) 1D
4 sht, 1:45:29 m.d., GMT+2 · EUR
search
Të gjitha simbolet
1D
5D
1M
6M
YTD
1V
5V
Maks
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për ALMKT...
Hap
0,16 €
I lartë
0,17 €
I ulët
0,16 €
Kapitalizimi i tregut
31,12Â mln
Vëllimi mesatar
520,81 mijë
Vëllimi
433,18 mijë
Raporti çmim/fitim
1,32
Maksimumi 52-javor
0,23 €
Minimumi 52-javor
0,07 €
Fitimet për aksion
0,12 €
Aksionet në qarkullim
195,26Â mln
Numri i punonjësve
59
Hap
0,16 €
I lartë
0,17 €
I ulët
0,16 €
Kapitalizimi i tregut
31,12Â mln
Vëllimi mesatar
520,81 mijë
Vëllimi
433,18 mijë
Raporti çmim/fitim
1,32
Maksimumi 52-javor
0,23 €
Minimumi 52-javor
0,07 €
Fitimet për aksion
0,12 €
Aksionet në qarkullim
195,26Â mln
Numri i punonjësve
59
Profili
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Rreth Mauna Kea Technologies SA
Drejtori ekzekutivSacha Loiseau
Punonjësit59
Themeluar më2000
Selia-
SektoriMedical device
Uebsajtimaunakeatech.com